MedTrace Logo

Early Onset Preeclampsia and Nectin-4

NCT05098691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2021-10-28

No results posted yet for this study

Summary

Early-onset Preeclampsia (PE) is a pregnancy disorder which may present with adverse pregnancy outcomes. Nectin-4 is an adhesion molecule mainly expressed in placenta. This study aimed to evaluate the relationship between early onset Preeclampsia and serum Nectin 4 levels.

Conditions

  • Pre-Eclampsia
  • Early Onset Preeclampsia
  • Oxidative Stress
  • Immunologic Diseases in Pregnancy

Interventions

DIAGNOSTIC_TEST

serum marker levels

two groups comparisons

Sponsors & Collaborators

  • Hatice Akkaya

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-12-15
Completion
2020-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05098691 on ClinicalTrials.gov